Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience.

Saved in:

Bibliographic Details
Title:	Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience.
Authors:	Razia D; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.; Department of Pulmonary Disease and Transplantation, Creighton University Health Sciences Phoenix Campus, Phoenix, AZ, United States., Sindu D; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States., Cherrier L; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.; Department of Pharmacy, University of Kentucky, Lexington, KY, United States., Grief K; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States., Walia R; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.; Department of Pulmonary Disease and Transplantation, Creighton University Health Sciences Phoenix Campus, Phoenix, AZ, United States., Tokman S; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.; Department of Pulmonary Disease and Transplantation, Creighton University Health Sciences Phoenix Campus, Phoenix, AZ, United States.
Source:	Frontiers in transplantation [Front Transplant] 2024 Jul 04; Vol. 3, pp. 1408289. Date of Electronic Publication: 2024 Jul 04 (Print Publication: 2024).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918573988006676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-2440 (Electronic) Linking ISSN: 28132440 NLM ISO Abbreviation: Front Transplant Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2813-2440
DOI:	10.3389/frtra.2024.1408289